Share Email Print
cover

Proceedings Paper

Performance assessment of 3D surface imaging technique for medical imaging applications
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Recent development in optical 3D surface imaging technologies provide better ways to digitalize the 3D surface and its motion in real-time. The non-invasive 3D surface imaging approach has great potential for many medical imaging applications, such as motion monitoring of radiotherapy, pre/post evaluation of plastic surgery and dermatology, to name a few. Various commercial 3D surface imaging systems have appeared on the market with different dimension, speed and accuracy. For clinical applications, the accuracy, reproducibility and robustness across the widely heterogeneous skin color, tone, texture, shape properties, and ambient lighting is very crucial. Till now, a systematic approach for evaluating the performance of different 3D surface imaging systems still yet exist. In this paper, we present a systematic performance assessment approach to 3D surface imaging system assessment for medical applications. We use this assessment approach to exam a new real-time surface imaging system we developed, dubbed "Neo3D Camera", for image-guided radiotherapy (IGRT). The assessments include accuracy, field of view, coverage, repeatability, speed and sensitivity to environment, texture and color.

Paper Details

Date Published: 8 March 2013
PDF: 11 pages
Proc. SPIE 8618, Emerging Digital Micromirror Device Based Systems and Applications V, 861803 (8 March 2013); doi: 10.1117/12.2001456
Show Author Affiliations
Tuotuo Li, Xigen LLC (United States)
Jason Geng, Xigen LLC (United States)
Shidong Li, Temple Univ. Hospital (United States)


Published in SPIE Proceedings Vol. 8618:
Emerging Digital Micromirror Device Based Systems and Applications V
Michael R. Douglass; Patrick I. Oden, Editor(s)

© SPIE. Terms of Use
Back to Top